Sporanox generic launches
Executive Summary
Eon launches first generic of Janssen's antifungal Sporanox (itraconazole) Feb. 9. Eon, which holds 180-day marketing exclusivity on itraconazole 100 mg capsules, received ANDA approval in May but was barred from launching by a temporary restraining order in Janssen's patent infringement lawsuit (1"The Pink Sheet" June 7, 2004, In Brief). A federal judge ruled in July that Eon's ANDA does not infringe; the case is under appeal. Eon says it timed its launch for the start of the heavy prescribing season for itraconazole...
You may also be interested in...
Sporanox patent ruling
Trial court's ruling that Eon's generic Sporanox (itraconazole) does not infringe a Janssen patent affirmed by the Federal Circuit June 13. Eon launched its generic in February with 180 days of marketing exclusivity (1"The Pink Sheet" Feb. 14, 2005, In Brief)...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.